Barinthus Biotherapeutics (BRNS) Shares Issued (2021 - 2025)
Historic Shares Issued for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q1 2025 value amounting to $2000.0.
- Barinthus Biotherapeutics' Shares Issued fell 9960.24% to $2000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $839000.0, marking a year-over-year decrease of 4153.31%. This contributed to the annual value of $2.2 million for FY2024, which is 628.99% up from last year.
- Per Barinthus Biotherapeutics' latest filing, its Shares Issued stood at $2000.0 for Q1 2025, which was down 9960.24% from $837000.0 recorded in Q4 2024.
- Barinthus Biotherapeutics' Shares Issued's 5-year high stood at $102.8 million during Q2 2021, with a 5-year trough of $2000.0 in Q1 2025.
- In the last 5 years, Barinthus Biotherapeutics' Shares Issued had a median value of $465000.0 in 2024 and averaged $9.8 million.
- As far as peak fluctuations go, Barinthus Biotherapeutics' Shares Issued surged by 91086.96% in 2024, and later tumbled by 9960.24% in 2025.
- Barinthus Biotherapeutics' Shares Issued (Quarter) stood at $102.8 million in 2021, then plummeted by 99.53% to $484000.0 in 2022, then plummeted by 77.48% to $109000.0 in 2023, then skyrocketed by 667.89% to $837000.0 in 2024, then tumbled by 99.76% to $2000.0 in 2025.
- Its Shares Issued was $2000.0 in Q1 2025, compared to $837000.0 in Q4 2024 and $465000.0 in Q3 2024.